Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul;42(4):386-396.
doi: 10.1016/j.currproblcancer.2018.05.005. Epub 2018 Jun 11.

Advanced imaging modalities to detect cardiotoxicity

Magid Awadalla  1 , Malek Z O Hassan  1 , Raza M Alvi  1 , Tomas G Neilan  2
Affiliations
Review

Advanced imaging modalities to detect cardiotoxicity

Magid Awadalla et al. Curr Probl Cancer. 2018 Jul.

Abstract

Recent advances in cancer treatments have significantly improved survival rates, reemphasizing the focus on reducing the potential complications associated with some therapies. Cardiovascular disease associated with chemotherapies is a major cause of morbidity and mortality in cancer survivors. Early detection of cardiotoxicity improves cardiac outcomes among cancer patients. The review will focus on imaging modalities used to assess cardiotoxicity - the cardiovascular consequences of chemotherapies. The review will discuss the benefits and limitations associated with each technique, as well as the guidelines available to help identify at risk patients. We will discuss novel techniques that may help detect earlier signs of cardiotoxicity, directing management that may improve clinical outcomes.

Keywords: Cardiac magnetic resonance; Cardiotoxicity; Chemotherapy; Computed tomography; Echocardiography; Ejection fraction; Radionuclide imaging.

PubMed Disclaimer

References

    1. Ong DS, Scherrer-Crosbie M, Coelho-Filho O, Francis SA, Neilan TG . Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction. Expert Rev Cardiovasc Ther. 2014. April;12:487–497, - PubMed
    1. Neilan T, Asnani A, Tripathy D, Scherrer-Crosbie M. Prevention and management of anthracycline cardiotox- icity. [cited 2018 Jan 10]; Available from: https://www.uptodate.com/contents/prevention-and-managementof-anthracycl....
    1. Wang DY, Okoye GD , Neilan TG, Johnson DB , Moslehi JJ. Cardiovascular toxicities associated with cancer immunotherapies. Curr Cardiol Rep. 2017. March;19:21. - PMC - PubMed
    1. Meyersohn NNM, Pursnani A, Neilan TG. Detection of cardiac toxicity due to cancer treatment: role of cardiac MRI. Curr Treat Options Cardiovasc Med, 2015. August;17:396, - PubMed
    1. Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J, 2016 September 21;37:2768–2801. - PubMed

Substances